Xbrane Biopharma AB (publ) (XBRANE.ST)

Home
XBRANE.ST
Financials

2.085 (SEK) • At close February 20, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Operating Activities:
Net Income Numbers are in millions	-322.028	-172.513	-188.376	-226.026	-166.037	-13.115	-44.935	-33.222	-11.551	-2.574	-2.107	-0.834
Depreciation & Amortization Numbers are in millions	21.433	16.576	12.998	6.566	7.326	4.323	3.992	8.539	1.441	0.055	0	0
Deferred Income Tax Numbers are in millions	-1.833	-25.421	-9.064	0	12.351	0	0	0	0	0	0	0
Stock Based Compensation Numbers are in millions	1.833	8.845	4.551	1.293	2.092	0.978	0.433	0	0	0	0	0
Change In Working Capital Numbers are in millions	-119.156	-30.732	-38.415	-18.628	-7.27	54.869	4.283	-14.677	-1.979	-0.151	-0.09	0
Accounts Receivables Numbers are in millions	-85.132	1.699	-61.086	-51.325	-28.286	-46.36	-7.441	-5.106	-2.093	-0.005	0	0
Inventory Numbers are in millions	-56.596	-50.26	-22.671	-32.697	0	-2.28	-0.568	-2.336	-0.161	0	0	0
Accounts Payables Numbers are in millions	22.572	17.829	22.671	32.697	42.968	103.509	12.292	-4.672	0.513	0	0	0
Other Working Capital Numbers are in millions	22.572	17.829	22.671	32.697	-21.952	57.149	4.851	-12.341	-1.818	-0.044	0	0
Other Non Cash Items Numbers are in millions	11.239	9.327	-1.304	-1.612	2.949	-0.348	3.803	-0.067	-0.299	0.002	0	0.834
Operating Cash Flow Numbers are in millions	-406.679	-193.918	-219.61	-238.407	-148.589	46.707	-36.849	-39.426	-12.387	-2.668	-2.197	0
Investing Activities:
Investments In Property Plant And Equipment Numbers are in millions	-16.769	-60.125	-77.35	-3.855	-1.187	-1.598	-3.347	-12.087	-1.146	-0.187	0	0
Acquisitions Net Numbers are in millions	0	0	0	0	0	0	0	0	0.019	0	0	0
Purchases Of Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0
Sales Maturities Of Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0
Other Investing Activites Numbers are in millions	-9.978	-48.509	-49.672	0	0	0	0	-0.635	0	0	0	0
Investing Cash Flow Numbers are in millions	-16.769	-60.125	-77.35	-3.855	-1.187	-1.598	-3.347	-12.722	-1.127	-0.187	0	0
Financing Activities:
Debt Repayment Numbers are in millions	-193.549	-8.337	-7.273	-0.012	-0.14	-0.131	-0.257	-9.778	-10	0	0	0
Common Stock Issued Numbers are in millions	119.056	170.551	380.87	346.447	252.457	3.25	20.004	90.577	0	0.18	10.709	0
Common Stock Repurchased Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing Activities Numbers are in millions	-0.001	-13.35	-24.232	-23.711	-36.276	44.611	-3.276	-9.778	10	0.18	0	0
Financing Cash Flow Numbers are in millions	298.696	148.864	349.365	322.724	216.041	47.73	16.728	80.799	10	0.18	10.709	0
Other Information:
Effect Of Forex Changes On Cash Numbers are in millions	-4.485	4.046	1.393	-1.52	-3.039	0.23	0.033	0	-0	0	0	0
Net Change In Cash Numbers are in millions	-128.592	-101.186	52.041	78.942	63.225	93.069	-23.435	28.651	-3.514	-2.676	8.512	0
Cash At End Of Period Numbers are in millions	65.402	193.994	295.18	243.139	164.197	100.972	7.903	31.338	2.688	6.201	8.877	0

Xbrane Biopharma AB (publ)

SSE:XBRANE.ST Add to watchlist

SSE:XBRANE.ST